How to Calculate Your Startup's Valuation (Without Making It Up)

Why early-stage valuation is not a science

Let's be honest: pre-revenue startup valuation is mostly a negotiation.

There's no formula that spits out "your company is worth $3.2M." You don't have revenue to apply multiples to. You don't have cash flows to discount. You have a team, an idea, maybe some early traction, and a story about the future.

At this stage, the valuation is determined by two things:

1. How much money you need. This is the starting point. Not "how much money would be nice to have" but "how much do I need to hit the milestones that make the next round possible?"

2. How much equity you're willing to give up. Standard practice is roughly 25% at your first round, then decreasing dilution at each subsequent round.

From these two numbers, the valuation falls out naturally:

• Need $500K? Willing to give up 25%? Your post-money valuation is $2M.
• Need $1M? Willing to give up 20%? Your post-money valuation is $5M.
• Need $3M? Willing to give up 15%? Your post-money valuation is $20M.

This is how most early-stage valuations actually get set. Not by DCF models. Not by comparable analysis. By working backwards from how much capital the business needs.

The dilution framework

Here's a rough framework that I've seen work across hundreds of deals:

Pre-seed round: ~25% dilution You're raising $100-500K. You're pre-revenue or very early. The round typically values the company at $1-3M post-money.

Seed round: ~20% dilution You're raising $1-3M. You have some traction - early customers, growing revenue, product-market fit signals. Valuations typically range from $5-15M post-money.

Series A: ~15-20% dilution You're raising $3-8M. You have clear product-market fit, meaningful revenue, and a path to scale. Valuations vary widely but $15-40M post-money is common.

Series B and beyond: ~10-15% dilution At this point, you have significant revenue and the valuation is increasingly driven by metrics and multiples rather than negotiation.

Why does dilution decrease over time? Because each round should de-risk the company. At pre-seed, you're mostly a bet on the team. By Series A, you've proven the product works. By Series B, you've proven the business works. Less risk = less dilution per dollar invested.

These are rough guidelines, not rules. Every deal is different. But if someone is asking you for 40% at your seed round, something is off.

Never lead with a valuation

This is the single most practical piece of fundraising advice I can give: do not put a number on the table first.

Here's why:

When you name a valuation, one of two things happens:

You go too low. The investor says "great, deal" and you've left money on the table. You'll never know what they would have offered.

You go too high. The investor thinks you're out of touch with reality and the conversation gets awkward. Even if they negotiate down, they might wonder what other assumptions you're getting wrong.

The better approach: Be very clear about how much money you want to raise. Be very clear about what you'll do with it. Then ask the investor: "Based on what you've seen, how would you price a company at our stage?"

Ask this to five or six investors. You'll quickly get a sense of the range. Some will say $3M. Some will say $5M. Now you know the market - and you can negotiate within that range from an informed position.

A few investors might push back and ask you to name a number first. That's fine - you can say: "We're focused on raising $X to achieve Y. We want to find the right partner who values the opportunity, and we're happy to discuss valuation once we've both decided there's a fit."

This isn't coy or evasive. It's strategic. You're not the person who has priced hundreds of startups. The investor is. Let them do what they're good at.

Australian valuation benchmarks

Australian valuations are significantly lower than US equivalents, but they've been rising steadily.

Very rough benchmarks for 2025-2026:

Important context: These numbers shift based on market conditions, sector, traction, and team. An AI company with strong early metrics will command a higher valuation than a marketplace with no revenue. A founder with a previous exit will get a premium over a first-time founder.

The US comparison: US pre-seed rounds are often $1-2M at $5-10M valuations. US seed rounds are $3-5M at $10-25M valuations. The gap is real, but it's narrowing - especially for companies that can demonstrate US-scale ambition from an Australian base.

Don't benchmark against US valuations unless you're raising from US investors. If you're raising from Australian angels and VCs, price relative to the Australian market. Telling an Australian investor your company is worth $10M at pre-seed because "that's what YC companies get" will not go well.

Valuation methods that actually work at each stage

Different methods make sense at different stages. Here's the breakdown:

Pre-seed and seed: The negotiation method

As discussed above - work backwards from how much you need and how much dilution is acceptable. Supplement with: - Comparable deals: What did similar companies in your market raise at? Ask your investors, ask other founders, check Crunchbase. - Accelerator benchmarks: If you went through an accelerator, the accelerator's standard terms give you a starting point.

Seed to Series A: The milestone method

At this stage, you can justify a higher valuation by pointing to milestones achieved since the last round: - Revenue growth (e.g. "We've gone from $5K to $50K MRR since our pre-seed") - Customer acquisition (e.g. "We have 200 paying customers, up from 10") - Team growth (e.g. "We've hired 5 engineers and a head of sales") - Product milestones (e.g. "We've launched our enterprise product")

Each milestone de-risks the business, which justifies a step-up in valuation.

Series B and beyond: Revenue multiples

Once you have meaningful recurring revenue, investors will use revenue multiples to benchmark your valuation:

Valuation = Annual Recurring Revenue (ARR) x Multiple

SaaS multiples vary widely based on growth rate, retention, and market size. In 2025-2026: - Slow growth SaaS (< 50% YoY): 5-10x ARR - Medium growth (50-100% YoY): 10-20x ARR - High growth (> 100% YoY): 20-50x+ ARR

These multiples compress and expand with market conditions. In 2021, high-growth SaaS commanded 50-100x ARR multiples. In 2023, those same companies traded at 10-20x. The market sets the multiple, not the founder.

The high valuation trap

One of the most counterintuitive truths in fundraising: raising at a high valuation can actually hurt you.

Here's the scenario. You raise a seed round at a $15M valuation. Things go well but not spectacularly - you grow, but not as fast as the $15M valuation implied. Now you need to raise a Series A.

The problem: To avoid a down round, you need to raise at $15M+ (ideally $30M+). But your metrics don't support that valuation yet. You're stuck - either raise a down round (which looks bad and dilutes you more), raise a flat round (which signals stagnation), or keep bootstrapping until your metrics catch up.

Compare that to: Raising a seed round at $8M. Same growth, same metrics at Series A time. But now you can comfortably raise at $20M, which looks like a strong step-up. Everyone's happy.

As Niki Scevak (Blackbird founder) once told me: "High valuation is a symptom, not a cause." A high valuation doesn't make your company more valuable. It just means you've set a higher bar for the next round.

My advice: Take the reasonable valuation, not the highest possible valuation. The money you raise is the same either way - but the pressure you put on yourself for the next round is very different.

Preparing for the valuation conversation

When you walk into investor meetings, be prepared for the valuation discussion with:

1. Your funding need. How much are you raising and why? Be specific: "We're raising $1.5M to hire three engineers, launch our enterprise product, and reach $100K MRR in 12 months."

2. Your milestone plan. What will you achieve with this capital? Investors want to see that the money gets the company to a clear inflection point.

3. Comparable deals. Know what similar companies raised at similar stages. Not to anchor the valuation, but to demonstrate you understand the market.

4. Your dilution comfort. Know what percentage you're willing to give up. Have a floor number in your head that you won't go below.

5. Multiple scenarios. Model what your cap table looks like at different valuations. If the investor offers $3M at a $12M valuation vs $3M at a $15M valuation, what's the actual ownership difference? (It's 20% vs 16.7% - meaningful, but not always worth fighting over.)

What you don't need: A DCF model, a TAM calculation that says your market is $50B, or a financial projection showing $100M revenue in Year 5. Nobody believes those numbers at early stage, and presenting them can actually undermine your credibility.

The bottom line

Startup valuation at the early stage is simpler than most founders make it.

Start with how much money you need. Apply a reasonable dilution percentage. That gives you a valuation range. Then let the market confirm or adjust it by talking to investors.

Don't lead with a number. Don't benchmark against Silicon Valley. Don't chase the highest possible valuation at the expense of a higher bar for your next round.

The best founders I've worked with treat valuation as a tool, not a trophy. It's the mechanism that determines how much equity you exchange for capital. Getting it right means raising enough to hit your milestones, at terms that leave you motivated and your investors happy.

Get the capital. Build the company. The valuation will take care of itself if the business is working.